PRE Stock Analysis: Buy, Sell, or Hold?
PRE - Prenetics Global Limited Class A Ordinary Share
$19.68
0.11 (0.56%)
ā²
5d:
-7.69%
30d:
+27.96%
90d:
+24.95%
HOLD
LOW Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: Feb 18, 2026
0d
Smart Money Accumulation
PRE is down 5.4% this week, but smart money is accumulating calls. Top strike: $17.5 2026-05-15 with 3 OI. Call ratio: 100% View Scanner →
Strength: 7.7/10
Get Alerted When PRE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
š HOLD: PRE shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
š HOLD: PRE shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
In-depth Analysis How we analyze
Valuation Analysis: PRE is currently trading at $19.68, which is considered fair relative to its 30-day fair value range of $17.24 to $21.48. From a valuation perspective, the stock is trading at a discount (Forward PE: -28.9) compared to its historical average (12.6). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, PRE is in a strong uptrend. Immediate support is located at $18.63, while resistance sits at $23.63.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $31.67 (+60.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PRE is in a strong uptrend. Immediate support is located at $18.63, while resistance sits at $23.63.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $31.67 (+60.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$17.24 -
$21.48
Company Quality Score
54/100
(HOLD)
Options IV Signal
47th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
75.8%
Protect Your Profits
Holding PRE? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Options fairly priced (IV 47th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 60.9% below Wall St target ($31.67)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- CAUTION: Recommendation downgraded due to -7.7% 5-day decline
Fair Price Analysis
30-Day Fair Range
$17.24 -
$21.48
Current vs Fair Value
FAIR
Expected Move (7 Days)
Ā±$3.59
(18.2%)
Support & Resistance Levels
Support Level
$18.63
Resistance Level
$23.63
Current Trend
Strong Uptrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-28.94
Wall Street Target
$31.67
(+60.9%)
Revenue Growth (YoY)
248.6%
Profit Margin
-63.1%
PE vs Historical
-28.9 vs 12.6
CHEAP
Share & Embed Analysis
Last updated: April 05, 2026 9:22 PM ET
Data refreshes hourly during market hours. Next update: 10:22 PM
Data refreshes hourly during market hours. Next update: 10:22 PM
š„ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PRE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientificā¦ |
STRONG BUY
31 analysts |
$664 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$265 | 67 BUY |
|
EXAS
EXACT Sciences Corporatiā¦ |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$133 | 56 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$261 | 62 BUY |
Advanced PRE Option Strategies
Professional options setups generated by AI based on today's PRE price and gamma walls.
